SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide
Li Du(City Of Hope National Medical Center), Steven T. Rosen(City of Hope)
Cited by 20
Related Papers
Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal
|Nature Communications|2016|132
Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
|Molecular Cancer Therapeutics|2006|81
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
|Journal of Hematology & Oncology|2021|66
SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|55
Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine
|Journal of Biological Chemistry|2009|44